A person in a white shirt holds a pen and reviews printed documents on a desk, possibly referencing ISO 20916 standards while making notes on text, charts, and colorful graphics.

What is ISO 20916?

ISO 20916 is an international standard for good study practice specifically for clinical performance studies using in vitro diagnostic medical devices (IVDs). It is referenced in recital (66) of the IVDR corrigendum of 03/05/2019:

“The rules on performance studies should be in line with well-established international guidance in this field, such as the international standard ISO 20916 on clinical performance studies using specimens from human subjects (…).”

The standard specifies how clinical performance studies are to be conducted under the IVDR and sets out requirements for key elements of study organisation and conduct, including:

  • Ethical considerations and informed consent of study participants
  • Study planning and roles/responsibilities (sponsor, investigator)
  • Clinical performance study design
  • Clinical performance study plan/protocol (CPSP), including endpoints
  • Investigator’s brochure
  • Study documentation and data integrity (e.g., CRF/eCRF, audit trail)
  • Management of adverse events
  • Selection and qualification of study sites
  • Monitoring plan, quality management, and audits
  • Study initiation
  • Study conduct
  • Study close-out, data analysis, and reporting

ISO 20916 Put Into Practice – A Brief Summary

To ensure robust results, define responsibilities and protect the subjects providing specimens, ISO 20916 specifies general requirements, such as:

  • Endpoints and population: clearly defined performance characteristics (e.g., sensitivity, specificity), and the IVD’s target population
  • Comparator: an appropriate reference method with justification
  • Specimen management: pre-analytical conditions, storage and retention of samples, and traceability
  • Statistics: sample size and analysis plan
  • Quality and safety: risk-based monitoring, deviations; reporting of adverse events and device deficiencies
  • Electronic systems, documents, and regulatory authorities: CPSP, Investigator’s Brochure, and CRF/eCRF; notification/authorisation to national authorities under the IVDR

Want to learn more about applying ISO 20916 and GCP in performance studies? Get in touch.

Dr. Nina Miljanovic Jovanovic, Senior Study Manager

You Might Also Be Interested In

A woman in a green lab coat and blue gloves types on a laptop at a CRF lab workstation, while another person in similar attire works in the background near laboratory equipment.

CRF briefly explained

How is study data collected and secured? Learn what constitutes a CRF (Case Report Form) and which requirements apply to validation and data protection.
A scientist wearing blue gloves and safety glasses examines samples on a slide through a microscope in a laboratory, conducting ivdr performance studies with scientific equipment visible in the background.

Diagnostics

From study planning through execution to submission-ready reports: TRIGA-S supports you with specialised expertise, a modular service portfolio, and a dedicated point of contact.
A scientist wearing safety goggles, gloves, and a lab coat stands in a laboratory specializing in pharma services, holding a piece of lab equipment and smiling at the camera. Shelves and lab supplies are visible in the background.

Pharma

From exploratory R&D analytics to submission-ready CDx validation: We support pharmaceutical companies with modular, IVDR-specialised services and dedicated points of contact.

CPSP: Clinical Performance Study Plan/Protocol

CRF: Case Report Form

eCRF: electronic Case Report Form

EUDAMED: European Database on Medical Devices

GCP: Good Clinical Practice

ISO: International Organization for Standardisation

IVDs: In vitro diagnostics

IVDR: In Vitro Diagnostic Regulation